The Group's principal activity is providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. The Group operates offices in 71 locations in 38 countries worldwide. During the 2008 the Group acquired 100% of Healthcare Discoveries Inc. and Prevalere Life Sciences Inc.
Alacra Alerts:
Receive alerts on the latest reports on ICON plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
